Extrusion technologies play a critical role in modern pharmaceutical manufacturing, enabling improved solubility, controlled release, and uniform drug distribution. As formulations become increasingly complex, partnering with experienced extrusion CDMO companies is essential to successfully develop and manufacture robust drug products at scale.
Specialized pharmaceutical extrusion CDMOs provide expertise in hot melt extrusion (HME), wet extrusion, and spheronization, supporting a wide range of dosage forms including pellets, granules, and modified-release systems. These partners ensure precise process control, regulatory compliance, and seamless scale-up from development to commercial production.